Search
Twitter-square Facebook-square Linkedin Youtube

MagSense® Applications & Pipeline

Molecularly targeted magnetism

MagSense® Clinical Pipeline

MagSense® products are disruptive – enabling molecular MRI for primary diagnosis & and staging, stand-alone diagnostics, and companion diagnostics.

Clinical Imaging

MagSense® HER2 Imaging Agent (MSH2IA)

MagSense® Ovarian Imaging Agent (MSFIA)

MagSense® Prostate Imaging Agent (MSPIA)

Vascular Imaging Agent

Pancreatic Cancer

DiscoveryPreclinical DevelopmentClinical Development
Phase 1 Complete
IND-enabling Nominee
In vivo PoC complete
In vivo PoC complete
POC in progress

Other Biomedical Applications

Hyperthermic
Tumor Ablation

Nanoparticle-based
Vaccines

Phase 1 on-going
Pre-commercial Supply
DiscoveryPreclinical DevelopmentClinical Development

Clinical Imaging

MagSense® HER2 Imaging Agent (MSH2IA)

Phase 1 Complete

MagSense® FR Imaging Agent (MSFIA)

IND-enabling Nominee

MagSense® PSMA Imaging Agent (MSPIA)

In vivo PoC complete

ContraMax® Vascular Imaging

In vivo PoC complete

Pancreatic Cancer

Prestiege Biopharma

Other Biomedical Applications

Hyperthermic Tumor Ablation

Phase 1 on-going

Nanoparticle-based Vaccines

Pre-commercial Supply

Explore the Science and the Study

Explore how our molecular MRI platform is shaping the future of cancer detection—or dive into our ongoing clinical trial focused on HER2+ breast cancer.
Learn about MagSense® mMRI
Explore the HER2 Clinical Trial

MagSense® Pre-Clinical and Clinical Applications

Transforming precision medicine to make better-informed decisions for patients’ diagnosis and treatment.

Learn more about our partnerships

If you’re looking to become a strategic partner to help design and drive clinical development, learn more about our collaboration opportunities.

Strategic Partnerships